Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2013
10/22/2013US8563040 Compositions and methods for forming and strengthening bone
10/22/2013US8563005 Actinobacillus suis antigens
10/22/2013US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
10/22/2013US8562967 Stable liquid formulations of G-CSF
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013US8562951 Methods for classifying and treating physiologic brain imbalances using quantitative EEG
10/22/2013US8562943 Quality control methods for oil-in-water emulsions containing squalene
10/22/2013CA2602776C Method for treating prostate diseases based on local delivery of active substances
10/22/2013CA2473526C Polyalkylene polymer compounds and uses thereof
10/22/2013CA2424001C Oral preparations with favorable disintegration characteristics
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/17/2013WO2013155381A1 Treatment for microbe-induced inflammatory responses in the eye
10/17/2013WO2013154794A1 Trans 10 : ci s 12 isomer of conjugated linoleic acid as a therapeutic and preventative agent for pregnancy induced hypertension or preeclampsia
10/17/2013WO2013154209A1 Antiprotozoan composition containing caspofungin or its salt and biguanide compound or its salt
10/17/2013WO2013154192A1 Medicinal composition for treating infarction
10/17/2013WO2013154163A1 Novel 5-aryl-1,2-thiazinane derivative
10/17/2013WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs
10/17/2013WO2013153146A1 Aggregate particles
10/17/2013US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor
10/17/2013US20130274342 Compositions and methods for treating cough
10/17/2013US20130274295 Pioglitazone for use in the treatment of adrenoleukodystrophy
10/17/2013US20130274294 4-(Hetero)Aryl-Ethynyl-Octahydro-Indole-1-Esters
10/17/2013US20130274290 Methods of use of cyclic amide derivatives to treat sigma receptor mediated disorders
10/17/2013US20130274274 Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
10/17/2013US20130274272 Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
10/17/2013US20130274270 Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
10/17/2013US20130274259 Kinase modulation and indications therefor
10/17/2013US20130274254 Inhibitors of cytochrome p450 (cyp3a4)
10/17/2013US20130274251 2-(2-phenylethenyl) 1,3-benzodiazepine compounds useful for the treatment of cancer
10/17/2013US20130274243 Chemical Compounds
10/17/2013US20130274239 Poly (adp-ribose) polymerase (parp) inhibitors
10/17/2013US20130274232 Pharmaceutical Compositions
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130274224 Sterile injectable aqueous formulation used in ophthalmology
10/17/2013US20130274220 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
10/17/2013US20130274219 Methods for treating non-small cell lung cancer using 5-azacytidine
10/17/2013US20130274218 Viral polymerase inhibitors
10/17/2013US20130274212 Sesterterpene Compounds and Use Thereof
10/17/2013US20130274208 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
10/17/2013US20130274202 Peptides for Treating Cancer
10/17/2013US20130274198 Treating muc1-expressing cancers with combination therapies
10/17/2013US20130274197 Benzodiazepinone compounds useful in the treatment of skin conditions
10/17/2013US20130274180 Pharmaceutical Compositions
10/17/2013US20130274179 Viral polymerase inhibitors
10/17/2013US20130273651 Differentiated cells suitable for human therapy
10/17/2013US20130273562 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target
10/17/2013US20130273177 Isoflavonoid compositions and methods for the treatment of cancer
10/17/2013US20130273151 MicroRNA Fingerprints During Human Megakaryocytopoiesis
10/17/2013US20130273115 Injectable filler
10/17/2013US20130273074 Methods and Compositions Using Anti-LPS Ligands for the Treatment and Prevention of Inflammatory Disorders
10/17/2013US20130273071 Recombinant IL-9 Antibodies And Uses Thereof
10/17/2013US20130273070 Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor
10/17/2013US20130273069 Pcsk9 antagonists
10/17/2013US20130273065 Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues
10/17/2013US20130273052 Polypeptides that bind to human complement component c5
10/17/2013US20130273050 Pharmaceutical compositions with resistance to soluble cea
10/17/2013US20130273045 Amino acyl trna synthetases for modulating inflammation
10/17/2013US20130273044 Compositions and Methods for Diagnosing and Treating Cancer
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273037 Compounds and methods for antiviral treatment
10/17/2013US20130273034 Novel compounds and compositions for the inhibition of nampt
10/17/2013US20130273030 Use of inhibitors of bruton's tyrosine kinase (btk)
10/17/2013US20130273029 Antibodies for epidermal growth factor receptor 3 (her3) directed to domain ii of her3
10/17/2013US20130273028 Plasminogen and plasmin variants
10/17/2013US20130273020 Antifungal composition
10/17/2013US20130273009 Methods to mobilize progenitor/stem cells
10/17/2013US20130273002 Multivalent breast cancer vaccine
10/17/2013US20130272999 Epidermal Growth Factor Composition, A Process Therefor and Its Application
10/17/2013US20130272996 Treatment of multiple sclerosis with laquinimod
10/17/2013US20130272992 Ion binding polymers and uses thereof
10/17/2013US20130272991 Ion binding polymers and uses thereof
10/17/2013US20130272990 Ion binding polymers and uses thereof
10/17/2013US20130272972 Oral Care Compositions Comprising a Quinone and a Further Antimicrobial Agent
10/17/2013US20130272968 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2013US20130272959 Agents for clearing biomolecules from circulation
10/16/2013EP2650020A1 Trimeric OX40-immunoglobulin fusion protein and methods of use
10/16/2013EP2650019A1 Noradrenergic and specific serotonergic antidepressant-containing transdermal patch
10/16/2013EP2649997A1 (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of antecedent hematologic disorders
10/16/2013EP2648747A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
10/16/2013EP2648734A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/16/2013EP2648727A2 Compositions and methods for mobilizing stem cells
10/16/2013EP2648725A1 TREATMENT OF CHRONIC INFLAMMATION WITH A 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVE
10/16/2013EP2648712A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
10/16/2013EP2648708A2 Combination for breast cancer therapy with hsp90 inhibitory compounds
10/16/2013EP2648704A1 Anti-microbial composition
10/16/2013EP2648703A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
10/16/2013EP2648700A1 Pharmaceutical composition comprising dutasteride
10/16/2013CN102309765B Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same
10/16/2013CN102210866B Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect
10/16/2013CN102068697B Opiates painkiller and opiate receptor antagonist-containing medicinal composition
10/16/2013CN101378761B Cationic steroid antimicrobial compositions and methods of use
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8557979 Carbapenem antibacterials with gram-negative activity and processes for their preparation
10/15/2013US8557859 Immunomodulatory compositions
10/15/2013US8557855 Methods of using ryanodine antagonists in treating neural injury
10/15/2013US8557851 Combinations of flupirtine and sodium channel inhibiting substances for treating pains
10/15/2013US8557789 Method of treating inflammatory arthropathies with supressors of CPG oligonucleotides
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557285 Pharmaceutical compositions for the coordinated delivery of NSAIDs
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 1151